Back to Search
ARTUR WOZNIAK, BSC, MD, FRCPC
BSC, MD, FRCPC
Diagnostic Radiology Physician
NPI: 1982419321Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
U7776(TX)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIV OF WESTERN ONTARIO SCHULICH SCHOOL OF MED
Class of 2016
Research & Publications (20)
Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis.
PMID 17130290·J Cell Biol·2006
8-other
Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer.
PMID 19493585·Lung Cancer·2010
3-trial
Complex tumor-specific t(X;18) in seven synovial sarcoma tumors.
PMID 19215793·Cancer Genet Cytogenet·2009
5-case
High efficacy of panobinostat towards human gastrointestinal stromal tumors in a xenograft mouse model.
PMID 19509176·Clin Cancer Res·2009
7-preclinical
The dynamics of the nitric oxide release-transient from stretched muscle cells.
PMID 18694846·Int J Biochem Cell Biol·2009
4-observational
An individual-based evolving predator-prey ecosystem simulation using a fuzzy cognitive map as the behavior model.
PMID 19463060·Artif Life·2009
7-preclinical
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
PMID 19225720·Invest New Drugs·2009
3-trial
Ectoparasites and associated pathogens of free-roaming and captive animals in zoos of South Carolina.
PMID 18973443·Vector Borne Zoonotic Dis·2009
7-preclinical
Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors.
PMID 18219445·Invest New Drugs·2008
3-trial
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.
PMID 18246046·Mod Pathol·2008
4-observational
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.
PMID 18978565·J Thorac Oncol·2008
3-trial
Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy.
PMID 19057272·J Thorac Oncol·2008
3-trial
Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.
PMID 18794084·Clin Cancer Res·2008
7-preclinical
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PMID 18758306·J Thorac Oncol·2008
3-trial
Changes in expression of serine proteases HtrA1 and HtrA2 during estrogen-induced oxidative stress and nephrocarcinogenesis in male Syrian hamster.
PMID 18231652·Acta Biochim Pol·2008
7-preclinical
Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature.
PMID 18184312·Am J Transplant·2008
5-case
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma.
PMID 18518789·Expert Opin Pharmacother·2008
6-review
Single-molecule FRET measures bends and kinks in DNA.
PMID 19020079·Proc Natl Acad Sci U S A·2008
8-other
Malignant ectomesenchymoma: genetic profile reflects rhabdomyosarcomatous differentiation.
PMID 18043289·Diagn Mol Pathol·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1320 S UNIVERSITY DR STE 500
FORT WORTH, TX 76107 - Phone
- (817) 321-0391
Quick Facts
- NPI
- 1982419321
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile